Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme-substrate interactions and QSARs for binding affinity and inhibition

被引:19
作者
Lewis, DFV [1 ]
Lake, BG
Dickins, M
Goldfarb, PS
机构
[1] Univ Surrey, Sch Biomed Life Sci, Guildford GU2 7XH, Surrey, England
[2] BIBRA Int Ltd, Carshalton SM5 4DS, Surrey, England
[3] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England
关键词
cytochromes p450; CYP2A6; homology modelling; QSARs;
D O I
10.1016/S0887-2333(02)00132-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The results of homology modelling of the human P450 enzyme CYP2A6, based on the CYP2C5 crystallographic template structure are reported. A substantial number of selective substrates of the CYP2A6 enzyme fit the putative active site in a manner that is consistent with their known metabolites. Moreover, the evidence from site-directed mutagenesis experiments is in accordance with the current model, particularly in relation to complementary amino acid contacts within the haem environment. The binding of substrates is rationalized in terms of QSAR analyses and from a consideration of the contributory factors affecting the binding affinity. The latter approach appears to represent a highly correlated (R=0.99) method for estimating the relative strength of enzyme-substrate binding within CYP2A6-selective compounds, albeit within a fairly limited dataset of substrates. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:179 / 190
页数:12
相关论文
共 51 条
[11]   2′-hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes:: Formation of a lung carcinogen precursor [J].
Hecht, SS ;
Hochalter, JB ;
Villalta, PW ;
Murphy, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12493-12497
[12]   The structure, function, and regulation of cytochrome P450 2A enzymes [J].
Honkakoski, P ;
Negishi, M .
DRUG METABOLISM REVIEWS, 1997, 29 (04) :977-996
[13]   Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment [J].
Ingelman-Sundberg, M ;
Oscarson, M ;
McLellan, RA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (08) :342-349
[14]   Identification of the cytochrome P450 isoforms involved in the O-demethylation of 4-nitroanisole in human liver microsomes [J].
Jones, BC ;
Tyman, CA ;
Smith, DA .
XENOBIOTICA, 1997, 27 (10) :1025-1037
[15]   STRUCTURAL ALTERATION OF MOUSE P450COH BY MUTATION OF GLYCINE-207 TO PROLINE - SPIN EQUILIBRIUM, ENZYME-KINETICS, AND HEAT SENSITIVITY [J].
JUVONEN, RO ;
IWASAKI, M ;
SUEYOSHI, T ;
NEGISHI, M .
BIOCHEMICAL JOURNAL, 1993, 294 :31-34
[16]  
KIMONEN T, 1995, BRIT J PHARMACOL, V116, P2625
[17]  
Lewis D F, 2001, Drug Metabol Drug Interact, V18, P221
[18]  
Lewis D. F. V., 2002, Xenobiotica, V32, P305, DOI 10.1080/00498250110112015
[19]  
Lewis DF., 1996, CYTOCHROMES P450 STR
[20]   Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity [J].
Lewis, DFV ;
Dickens, M ;
Lake, BG ;
Eddershaw, PJ ;
Tarbit, MH ;
Goldfarb, PS .
TOXICOLOGY, 1999, 133 (01) :1-33